Current evidence for COVID-19 therapies: a systematic literature review
Current evidence for COVID-19 therapies: a systematic literature review – European Respiratory Review
The post Current evidence for COVID-19 therapies: a systematic literature review appeared first on Links Medicus.
European Medicines Agency finds AstraZeneca vaccine is safe and benefits outweigh the risks
COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets – European Medicines Agency Commentaries: Restoring confidence after the covid-19 Oxford/AstraZeneca vaccine pause will be an uphill battle – The BMJ Opinion AND European Medicines Agency: AstraZeneca Vaccine Safe – Benefits Outweigh Risks – Despite Possible […]
The post European Medicines Agency finds AstraZeneca vaccine is safe and benefits outweigh the risks appeared first on Links Medicus.
RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial – JAMA Editorial: Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19 – JAMA Commentary on Twitter Intermediate-dose prophylactic enoxaparin (1 mg/kg/d) had […]
The post RCT: Intermediate-dose enoxaparin (1 mg/kg/d) not better than standard-dose prophylactic anticoagulation in patients with Covid-19 admitted to the intensive care unit appeared first on Links Medicus.
The use of extracorporeal CO2 removal in acute respiratory failure
The use of extracorporeal CO2 removal in acute respiratory failure – Annals of Intensive Care
The post The use of extracorporeal CO2 removal in acute respiratory failure appeared first on Links Medicus.
COVID-19 vaccines vs. variants—determining how much immunity is enough
COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough – JAMA
The post COVID-19 vaccines vs. variants—determining how much immunity is enough appeared first on Links Medicus.
Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19 – JAMA Editorial: Outcomes for Patients Following Hospitalization for COVID-19
The post Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19 appeared first on Links Medicus.
Why Opening Windows Is a Key to Reopening Schools
Why Opening Windows Is a Key to Reopening Schools – The New York Times (free registration may be required) Commentary on Twitter Stunning #AR imagery to underscore the importance of ventilation and window opening for countering covid in schools (and all places) https://t.co/uWhJie1Sku by @NickBartzokas and colleagues w/ @j_g_allen ✓ out the digital version pic.twitter.com/gXxjH1VbTo […]
The post Why Opening Windows Is a Key to Reopening Schools appeared first on Links Medicus.
Just How Do Deaths Due to COVID-19 Stack Up?
Just How Do Deaths Due to COVID-19 Stack Up? – Think Global Health Commentary on Twitter (thread – click for more) The Americas and Europe accounted for 80% of COVID-19 deaths globally, even though they represent only a quarter of the world's population. @ThinkGlobalHlth launches a tracker of COVID as a cause of death […]
The post Just How Do Deaths Due to COVID-19 Stack Up? appeared first on Links Medicus.
Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19
Thoracic imaging tests for the diagnosis of COVID‐19 – Cochrane Library
The post Systematic Review: Thoracic imaging tests for the diagnosis of COVID‐19 appeared first on Links Medicus.
Population Study: Past Covid-19 confers 80.5% protection against reinfection, which decreases to 47.1% in those aged 65 years and older
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study – The Lancet Commentaries: Risk of SARS-CoV-2 reinfection after natural infection – The Lancet AND COVID-19 Reinfection: More Common Than We Think? – MedPage Today (free registration required) Commentary on Twitter NEW—Most people who […]
The post Population Study: Past Covid-19 confers 80.5% protection against reinfection, which decreases to 47.1% in those aged 65 years and older appeared first on Links Medicus.